A study looking at the genetics of cancers of the eyelid
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Cancer type:
Status:
Phase:
This study is looking at the genetics of skin cancers of the eyelid.
The researchers want to collect tissue samples of skin cancers of the eyelid. They will look at the 
in the cells of the tissue samples to find out
- Why some people develop cancer of the eyelid
- Why some people’s cancer continues to grow despite treatment or comes back very quickly after treatment
- If there is a way to predict if a person’s cancer may get better or worse over time
- If they can develop better treatments for people with cancer of the eyelid
Taking part in the study will not affect your treatment and may not help you directly. The information from this study may in the future help people with cancer of the eyelid.
Who can enter
You may be able to join this study if you are at least 18 years old and have one of the following types of skin cancer on or near your eyelid
You cannot join this study if you have had chemotherapy or radiotherapy to treat your skin cancer of the eyelid.
Trial design
The researchers need 79 to join this study.
The researchers will ask for a sample of your cancer that was removed when you had surgery or a . They will also ask for a blood sample.
They may ask you for more information about your cancer and more tissue samples of your cancer in the future. You don’t have to agree to this, you can still take part in the main study.
Hospital visits
There may be an extra visit to the hospital if you agree to give more information or tissue samples of your cancer.
Side effects
You may feel some discomfort or have some bruising from where they take the blood sample.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr John Bladen
Supported by
Fight for Sight (British Eye Research Foundation)
NIHR Clinical Research Network: Cancer
Queen Mary University of London
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
